Please Wait.....
Report
North America Stem Cell Assay Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 120 Pages I EMR Inc.
North America Stem Cell Assay Market Report and Forecast 2024-2032
North America Stem Cell Assay Market Outlook
The North America stem cell assay market size was valued at USD 7.1 billion in 2023, driven by the increased investment in stem cell research in the region. The market is expected to grow at a CAGR of 10.10% during the forecast period of 2024-2032, with the values likely to rise from USD 7.8 billion in 2024 to USD 16.9 billion by 2032.
Key Takeaways
- In May 2023 , a study published in Cell Reports Medicine revealed that a cancer stem cell assay called ChemoID can accurately predict clinical outcomes in response to chemotherapy, improving the survival of patients with recurrent glioblastoma.
- In April 2023, Discovery Life Sciences acquired ReachBio Research Labs to expand its offerings in drug discovery and preclinical development by leveraging ReachBio's expertise in primary cell biology, particularly blood and bone marrow stem cell assays.
- According to the American Cancer Society, it is estimated that 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States in 2024.
Stem cell assay is a laboratory technique that helps to evaluate the behavior and function of stem cells. These assays find their applications in studying stem cell biology and assessing their potential therapeutic use. The rising cases of various chronic diseases in the region such as cancer are expected to directly impact the demand for novel treatment options, thereby driving the North America stem cell assay market growth. For instance, according to the American Cancer Society, it is estimated that 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States in 2024. Further, increased applications of stem cell assays in drug discovery and regenerative medicine are likely to augment the market size in the forecast period.
In North America, the rising impetus for stem cell research is resulting in advancements in stem cell assay methods and therapies. The development of innovative methods is expected to boost North America stem cell assay market demand as they can assist healthcare professionals in personalizing chemotherapy selection for cancer patients and in identifying the most effective therapy for each patient. In May 2023 , a study published in Cell Reports Medicine revealed that a cancer stem cell assay called ChemoID can accurately predict clinical outcomes in response to chemotherapy, improving the survival of patients with recurrent glioblastoma. In the randomized trial, the group guided by the ChemoID assay showed a median survival of 12.5 months, compared to 9 months in the physician-choice group. These findings offer a promising approach to providing more affordable treatment for patients with recurrent glioblastoma in lower socioeconomic groups in the United States.
North America stem cell assay market share is likely to be impacted by increased merger and acquisition initiatives among the key market players. In April 2023, a United States-based company specializing in biospecimen, biomarker, and proteogenomics Discovery Life Sciences acquired ReachBio Research Labs, a life sciences company based in Seattle known for their cell-based assays, drug screening services, and predictive hematotoxicity. The acquisition will enable Discovery Life Science to expand its offerings in drug discovery and preclinical development by leveraging ReachBio's expertise in primary cell biology, particularly blood and bone marrow stem cell assays. The growing number of such strategic partnerships is anticipated to accelerate market growth in the coming years.
Other factors that fuel the market growth are the advancements in stem cell technologies resulting in enhanced efficiency and throughput of stem cell assays, increased healthcare expenditure, and rising funding for stem cell-based research. Further, the growing demand for personalized medicine and precision therapies will accelerate the market growth in the region.
North America Stem Cell Assay Market Segmentation??
"North America Stem Cell Assay Market Report and Forecast 2024-2032" offers a detailed analysis of the market based on the following segments:
Market Breakup by Product & Service
- Flow Cytometers
- Cell Imaging & Analysis Systems
- Microelectrode Arrays
- Automated Cell Counters
- Kits
Market Breakup by Cell Type
- Adult Stem Cells
- Human Embryonic Stem Cells
- Pluripotent
Market Breakup by Type
- Viability/Cytotoxicity Assays
- Isolation & Purification Assays
- Cell Identification Assays
- Proliferation Assays
- Differentiation Assays
- Function Assays
- Apoptosis Assays
- Others
Market Breakup by Treatment
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
- Syngeneic Stem Cell Therapy
Market Breakup by Application
- Regenerative Medicine & Therapy Development
- Drug Discovery & Development
- Clinical Research
- Others
Market Breakup by End User
- Biopharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
Market Breakup by Countries
- United States of America
- Canada
North America Stem Cell Assay Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- Perkinelmer
- Stemcell Technologies
- Merck
- Bio-Rad Laboratories
- Agilent Technologies
- Promega
- Bio-Techne
- Cell Biolabs
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What was the North America stem cell assay market value in 2023?
The market attained a value of about USD 7.1 billion in 2023 driven by the increased investment in stem cell research in the region.
- What is the North America stem cell assay market forecast outlook for 2024-2032?
The market is anticipated to grow at a CAGR of 10.08% during the forecast period of 2024-2032, likely to reach a market value of USD 16.9 billion by 2032.
- What are the major factors aiding the North America stem cell assay market demand?
The growing prevalence of chronic diseases and the rising healthcare expenditure are fuelling the demand for the market.
- What are the major North America stem cell assay market trends?
One of the significant trends in the market is the increased merger and acquisition initiatives among the key market players. In April 2023, Discovery Life Sciences acquired ReachBio Research Labs, a life sciences company based in Seattle known for its cell-based assays, drug screening services, and predictive hematotoxicity.
- What is the market segmentation based on product and services?
Based on the product and services, the market is segmented into flow cytometers, cell imaging and analysis systems, microelectrode arrays, automated cell counters, and kits.
- What are the various treatments available in the market?
Treatments available in the market include allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy.
- What is the market breakup by type?
By type, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays, among others.
- What is the market segmentation based on the cell type?
The market breakup by cell type includes adult stem cells, human embryonic stem cells, and pluripotent.
- What are the major end users of stem cell assay?
End users of the market are biopharmaceutical and biotechnology companies, as well as academic and research institutes, among others.
- What are the applications of stem cell assay?
Major applications areas of stem cell assays include regenerative medicine and therapy development, drug discovery and development, along with clinical research, among others.
- What is the market segmentation by countries?
The market segmentation by countries includes the United States of America and Canada.
- Who are the key players involved in the North America stem cell assay market?
The key market players include Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne, and Cell Biolabs.
Meta description
The North America stem cell assay market size was valued at USD 7.1 billion in 2023 and it is anticipated to grow at a CAGR of 10.08% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Stem Cell Assay Market Overview
3.1 North America Stem Cell Assay Market Historical Value (2017-2023)
3.2 North America Stem Cell Assay Market Forecast Value (2024-2032)
4 North America Stem Cell Assay Market Landscape*
4.1 North America Osmometers: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Osmometers: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Cell Type
4.2.3 Analysis by Treatment
5 North America Stem Cell Assay Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Stem Cell Assay Market Segmentation (2017-2032)
6.1 North America Stem Cell Assay Market (2017-2032) by Product & Service
6.1.1 Market Overview
6.1.2 Flow Cytometers
6.1.3 Cell Imaging & Analysis Systems
6.1.4 Microelectrode Arrays
6.1.5 Automated Cell Counters
6.1.6 Kits
6.2 North America Stem Cell Assay Market (2017-2032) by Cell Type
6.2.1 Market Overview
6.2.2 Adult Stem Cells
6.2.3 Human Embryonic Stem Cells
6.2.4 Pluripotent
6.3 North America Stem Cell Assay Market (2017-2032) by Type
6.3.1 Market Overview
6.3.2 Viability /Cytotoxicity Assays
6.3.3 Isolation & Purification Assays
6.3.4 Cell Identification Assays
6.3.5 Proliferation Assays
6.3.6 Differentiation Assays
6.3.7 Function Assays
6.3.8 Apoptosis Assays
6.3.9 Others
6.4 North America Stem Cell Assay Market (2017-2032) by Treatment
6.4.1 Market Overview
6.4.2 Allogeneic Stem Cell Therapy
6.4.3 Autologic Stem Cell Therapy
6.4.4 Syngeneic Stem Cell Therapy
6.5 North America Stem Cell Assay Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Regenerative Medicine &Therapy Development
6.5.3 Drug Discovery & Development
6.5.4 Clinical Research
6.5.5 Others
6.6 North America Stem Cell Assay Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Biopharmaceutical & Biotechnology Companies
6.6.3 Academic & Research Institutes
6.6.4 Others
6.7 North America Stem Cell Assay Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 United States of America
6.7.3 Canada
7 United States of America of Stem Cell Assay Market (2017-2032)
7.1 United State of America Stem Cell Assay Market (2017-2032) by Product & Service
7.1.1 Market Overview
7.1.2 Flow Cytometers
7.1.3 Cell Imaging & Analysis Systems
7.1.4 Microelectrode Arrays
7.1.5 Automated Cell Counters
7.1.6 Kits
7.2 United States of America Stem Cell Assay Market (2017-2032) by Cell Type
7.2.1 Market Overview
7.2.2 Adult Stem Cells
7.2.3 Human Embryonic Stem Cells
7.2.4 Pluripotent
7.3 United States of America Stem Cell Assay Market (2017-2032) by Type
7.3.1 Market Overview
7.3.2 Viability /Cytotoxicity Assays
7.3.3 Isolation & Purification Assays
7.3.4 Cell Identification Assays
7.3.5 Proliferation Assays
7.3.6 Differentiation Assays
7.3.7 Function Assays
7.3.8 Apoptosis Assays
7.3.9 Others
7.4 United State of America Stem Cell Assay Market (2017-2032) by Treatment
7.4.1 Market Overview
7.4.2 Allogeneic Stem Cell Therapy
7.4.3 Autologic Stem Cell Therapy
7.4.4 Syngeneic Stem Cell Therapy
7.5 United State of America Stem Cell Assay Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Biopharmaceutical & Biotechnology Companies
7.5.3 Academic & Research Institutes
7.5.4 Others
7.6 United State of America Stem Cell Assay Market (2017-2032) by Application
7.6.1 Market Overview
7.6.2 Regenerative Medicine &Therapy Development
7.6.3 Drug Discovery & Development
7.6.4 Clinical Research
7.6.5 Others
8 Canada Stem Cell Assay Market (2017-2032)
8.1 Canada Stem Cell Assay Market (2017-2032) by Product & Service
8.1.1 Market Overview
8.1.2 Flow Cytometers
8.1.3 Cell Imaging & Analysis Systems
8.1.4 Microelectrode Arrays
8.1.5 Automated Cell Counters
8.1.6 Kits
8.2 Canada Stem Cell Assay Market (2017-2032) by Cell Type
8.2.1 Market Overview
8.2.2 Adult Stem Cells
8.2.3 Human Embryonic Stem Cells
8.2.4 Pluripotent
8.3 Canada Stem Cell Assay Market (2017-2032) by Type
8.3.1 Market Overview
8.3.2 Viability /Cytotoxicity Assays
8.3.3 Isolation & Purification Assays
8.3.4 Cell Identification Assays
8.3.5 Proliferation Assays
8.3.6 Differentiation Assays
8.3.7 Function Assays
8.3.8 Apoptosis Assays
8.3.9 Others
8.4 Canada Stem Cell Assay Market (2017-2032) by Treatment
8.4.1 Market Overview
8.4.2 Allogeneic Stem Cell Therapy
8.4.3 Autologic Stem Cell Therapy
8.4.4 Syngeneic Stem Cell Therapy
8.5 Canada Stem Cell Assay Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Biopharmaceutical & Biotechnology Companies
8.5.3 Academic & Research Institutes
8.5.4 Others
8.6 Canada Stem Cell Assay Market (2017-2032) by Application
8.6.1 Market Overview
8.6.2 Regenerative Medicine &Therapy Development
8.6.3 Drug Discovery & Development
8.6.4 Clinical Research
8.6.5 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Thermo Fisher Scientific
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Perkinelmer
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Stemcell Technologies
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Merck
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Bio-Rad Laboratories
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Agilent Technologies
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Promega
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Bio-Techne
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Cell Biolabs
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
14 United States of America Cannula Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security